市場調査レポート

商品コード

1084876

細胞毒性薬受託製造の市場規模・シェア・展望・機会 (2022年～2028年)：生産規模・形態・製品タイプ・地域別

Cytotoxic Drugs Contract Manufacturing Market, by Production Scale, by Form, by Product Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: 2022年05月29日 | 発行: Coherent Market Insights

| ページ情報: 英文 193 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 699,570円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,088,220円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,554,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.46円

全表示
概要
目次

概要

サンプル依頼リストに入れる

細胞毒性薬受託製造市場は過去10年で大きく成長しました。癌の発生率の増加や、主要企業による事業の拡大、提携、買収などの各種成長戦略の増加などの要因が予測期間中の市場成長を後押しすると予想されています。また、製薬企業による受託製造サービスの採用の増加も予測期間中の市場成長を促進すると予想されています。

当レポートでは、世界の細胞毒性薬受託製造の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、技術動向、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

ヒートマップ分析
市場シェア分析
- Lonza Group
- Piramal Group
- Evonik Industries AG
- Novasep Holding SAS
- Merck KGaA(SAFC Pharma)
- Baxter Biopharma Solutions
- AbbVie Contract Manufacturing
- Cambrex Corporation
- CordenPharma International
- BSP Pharmaceuticals SpA
- Catalent, Inc.
- Albany Molecular Research Inc.(AMRI)
- Evotec
- WuXi AppTec Co., Ltd.
- Pierre Fabre Laboratories
- Dishman Group
アナリストの見解

第9章セクション

Product Code: CMI3175

Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost market growth over the forecast period. Pharmaceutical and biotechnological companies are involved in research and development of cytotoxic drugs and high potency active pharmaceutical ingredients (HPAPIs), and in the manufacture of drugs in-house or outsource the production to other manufacturers.

Market Dynamics

Rising incidence of cancer is expected to propel the market growth over the forecast period. For instance, according to an American Cancer Society estimations, 2017, 1,688,780 people were estimated to be diagnosed with cancer and 600,920 cancer deaths were reported in the U.S.

Increasing product approval for the treatment of cancer is expected to boost growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in October 2021, Catalent Pharma Solutions received the approval of U.S. Food and Drug Administration (FDA) for Verastem Oncology's COPIKTRA (duvelisib) capsules.

Furthermore, rising adoption of contract manufacturing services by the pharmaceutical companies is expected to drive growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in September 2021, GB Sciences, Inc. selected Catalent Pharma Solutions to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients (APIs) for its Parkinson's disease therapies.

Key features of the study:

This report provides in-depth analysis of the cytotoxic drugs contract manufacturing market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cytotoxic drugs contract manufacturing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as part of this study include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
The global cytotoxic drugs contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cytotoxic drugs contract manufacturing market

Detailed Segmentation:

Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale:
- Industrial scale
- Pilot Scale
- Laboratory Scale
Global Cytotoxic Drugs Contract Manufacturing Market, By Form:
- Liquid
- Solid
Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type:
- Oral
- Intravenous
Global Cytotoxic Drugs Contract Manufacturing Market, By Region:
- North America
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Production Scale:
  - Industrial scale
  - Pilot Scale
  - Laboratory Scale
  - By Form:
  - Liquid
  - Solid
  - By Product Type:
  - Oral
  - Intravenous
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Lonza Group*
  - Company Overview
  - Material Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Piramal Group
- Evonik Industries AG
- Novasep Holding SAS
- Merck KGaA (SAFC Pharma)
- Baxter Biopharma Solutions
- AbbVie Contract Manufacturing
- Cambrex Corporation
- BSP Pharmaceuticals S.p.A.
- CordenPharma International
- Catalent, Inc.
- Albany Molecular Research Inc. (AMRI)
- Evotec
- WuXi AppTec Co., Ltd.
- Pierre Fabre Laboratories
- Dishman Group

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Production Scale
- Market Snippet, By Form
- Market Snippet, By Product Type
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Epidemiology
Market Trends
Product Launch
Regulatory Scenario
PEST Analysis
Merger and Acquisition Scenario
Technological Advancements

4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028(%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Industrial scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Pilot Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Laboratory Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028(%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Liquid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Solid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028(%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Lonza Group
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Piramal Group
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Evonik Industries AG
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novasep Holding SAS
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck KGaA (SAFC Pharma)
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter Biopharma Solutions
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Contract Manufacturing
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cambrex Corporation
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CordenPharma International
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BSP Pharmaceuticals S.p.A.
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Catalent, Inc.
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Albany Molecular Research Inc. (AMRI)
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Evotec
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- WuXi AppTec Co., Ltd.
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pierre Fabre Laboratories
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dishman Group
- Company Overview
- Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Analyst Views

9. Section

References
Research Methodology
About Us and Sales Contact

細胞毒性薬受託製造の市場規模・シェア・展望・機会 (2022年～2028年)：生産規模・形態・製品タイプ・地域別

Cytotoxic Drugs Contract Manufacturing Market, by Production Scale, by Form, by Product Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・法規制・動向分析

第4章世界の細胞毒性薬受託製造市場：生産規模別

第5章世界の細胞毒性薬受託製造市場：形態別

第6章世界の細胞毒性薬受託製造市場：製品タイプ別

第7章世界の細胞毒性薬受託製造市場：地域別

第8章競合情勢

第9章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2017 - 2028, (US$ Mn)

5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2017 - 2028, (US$ Mn)

6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2017 - 2028, (US$ Mn)

7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2017 - 2028, (US$ Mn)

8. Competitive Landscape

9. Section

細胞毒性薬受託製造の市場規模・シェア・展望・機会 (2022年～2028年)：生産規模・形態・製品タイプ・地域別

Cytotoxic Drugs Contract Manufacturing Market, by Production Scale, by Form, by Product Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・法規制・動向分析

第4章 世界の細胞毒性薬受託製造市場：生産規模別

第5章 世界の細胞毒性薬受託製造市場：形態別

第6章 世界の細胞毒性薬受託製造市場：製品タイプ別

第7章 世界の細胞毒性薬受託製造市場：地域別

第8章 競合情勢

第9章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2017 - 2028, (US$ Mn)

5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2017 - 2028, (US$ Mn)

6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2017 - 2028, (US$ Mn)

7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2017 - 2028, (US$ Mn)

8. Competitive Landscape

9. Section

第1章調査目的・前提条件

第2章市場概要

第3章市場力学・法規制・動向分析

第4章世界の細胞毒性薬受託製造市場：生産規模別

第5章世界の細胞毒性薬受託製造市場：形態別

第6章世界の細胞毒性薬受託製造市場：製品タイプ別

第7章世界の細胞毒性薬受託製造市場：地域別

第8章競合情勢

第9章セクション